The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...
Stocks like Wipro, Walchandnagar Industries, Hindustan Zinc, R Systems International, Kirloskar Industries, Zaggle Prepaid ...
Zydus Lifesciences Ltd is quoting at Rs 906.2, up 2.11% on the day as on 12:49 IST on the NSE. The stock is down 7.22% in last one year as compared to a 0.19% fall in NIFTY and a 6.32% fall in the ...
Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...
Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug ...
Benchmark BSE Sensex surged by 740 points while Nifty snapped its 10-day losing streak on Wednesday (March 5) following value ...
The company launched ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients. ANVIMO will ...
Zydus Lifesciences is developing a combination vaccine targeting shigellosis and typhoid, with support from the Gates ...
Veteran Bollywood actor Anupam Kher is set to bring the inspiring life story of Padma Bhushan Pankaj Patel, the renowned ...
Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...
Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...
Traditional CMV treatments, such as ganciclovir and valganciclovir, have notable limitations, including toxicity and bone marrow suppression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results